Cover Image
市場調查報告書

Sol-Gel Technologies Ltd. - 產品平台分析

Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 311248
出版日期 內容資訊 英文 18 Pages
訂單完成後即時交付
價格
Back to Top
Sol-Gel Technologies Ltd. - 產品平台分析 Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014
出版日期: 2014年08月25日 內容資訊: 英文 18 Pages
簡介

Sol-Gel Technologies是針對護膚(皮膚科學)市場轉門開發及製造的製藥公司。該公司的產品有抗粉刺套件製劑,及以BPO(過氧化苯甲醯)為基礎開發粉刺治療藥,不久即將上市。此外也在開發酒糟治療的外用藥。

本報告提供Sol-Gel Technologies Ltd.的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Sol-Gel Technologies Ltd.的基本資料

Sol-Gel Technologies Ltd.概要

  • 主要資訊
  • 企業資料

Sol-Gel Technologies Ltd.:R&D概要

  • 主要的治療範圍

Sol-Gel Technologies Ltd.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Sol-Gel Technologies Ltd.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Sol-Gel Technologies Ltd.:藥物簡介

  • DER-45EV
  • SGTSZ-91
  • SGTTN-65
  • 各給藥途徑

Sol-Gel Technologies Ltd.:暫停中的計劃

Sol-Gel Technologies Ltd.:總公司和子公司的所在地

附錄

圖表一覽

目錄
Product Code: GMDHC06099CDB

Summary

Global Markets Direct's, 'Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014', provides an overview of the Sol-Gel Technologies Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Sol-Gel Technologies Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Sol-Gel Technologies Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Sol-Gel Technologies Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Sol-Gel Technologies Ltd.'s pipeline products

Reasons to buy

  • Evaluate Sol-Gel Technologies Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Sol-Gel Technologies Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Sol-Gel Technologies Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Sol-Gel Technologies Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sol-Gel Technologies Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Sol-Gel Technologies Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Sol-Gel Technologies Ltd. Snapshot
    • Sol-Gel Technologies Ltd. Overview
    • Key Information
    • Key Facts
  • Sol-Gel Technologies Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Sol-Gel Technologies Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Sol-Gel Technologies Ltd. - Pipeline Products Glance
    • Sol-Gel Technologies Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Sol-Gel Technologies Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Sol-Gel Technologies Ltd. - Drug Profiles
    • DER-45EV
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SGTSZ-91
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SGTTN-65
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Sol-Gel Technologies Ltd. - Pipeline Products by Route of Administration
  • Sol-Gel Technologies Ltd. - Dormant Projects
  • Sol-Gel Technologies Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Sol-Gel Technologies Ltd., Key Information
  • Sol-Gel Technologies Ltd., Key Facts
  • Sol-Gel Technologies Ltd. - Pipeline by Indication, 2014
  • Sol-Gel Technologies Ltd. - Pipeline by Stage of Development, 2014
  • Sol-Gel Technologies Ltd. - Monotherapy Products in Pipeline, 2014
  • Sol-Gel Technologies Ltd. - Phase II, 2014
  • Sol-Gel Technologies Ltd. - Preclinical, 2014
  • Sol-Gel Technologies Ltd. - Pipeline by Route of Administration, 2014
  • Sol-Gel Technologies Ltd. - Dormant Developmental Projects,2014

List of Figures

  • Sol-Gel Technologies Ltd. - Pipeline by Top 10 Indication, 2014
  • Sol-Gel Technologies Ltd. - Pipeline by Stage of Development, 2014
  • Sol-Gel Technologies Ltd. - Monotherapy Products in Pipeline, 2014
  • Sol-Gel Technologies Ltd. - Pipeline by Top 10 Route of Administration, 2014
Back to Top